IC
SRTAW

IEQ Capital’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

IEQ Capital’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$1.9K – 1342
2024
Q3 		$1.9K Hold
10,000
– – ﹤0.01% 1156
2024
Q2 		$1.69K Buy
+10,000
New +$2.57K ﹤0.01% 1005

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

IEQ Capital's SRTAW Position: Q4 2024 in Review

IEQ Capital sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q4 2024, closing a stake of 10,000 shares — an estimated $1.9K sold.

IEQ Capital first reported a position in SRTAW in Q2 2024 and held it in 2 quarters. The position peaked at $1.9K in Q3 2024. 8 funds tracked by Wall St. Rank hold SRTAW as of Q4 2024.

  • IEQ Capital reported no remaining Strata Critical Medical Inc Warrants position as of Q4 2024 after selling out during the quarter.
  • IEQ Capital sold 10,000 Strata Critical Medical Inc Warrants shares in Q4 2024, an estimated $1.9K.
  • IEQ Capital first reported a position in Strata Critical Medical Inc Warrants in Q2 2024 and held it in 2 quarters.
  • IEQ Capital's Strata Critical Medical Inc Warrants position peaked at $1.9K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q4 2024.

Based on IEQ Capital's 13F filing for Q4 2024, filed 3 Feb 2025.